首页> 外文期刊>International Orthopaedics >A prospective randomized trial of percutaneous marrow injection in a series of closed fresh tibial fractures.
【24h】

A prospective randomized trial of percutaneous marrow injection in a series of closed fresh tibial fractures.

机译:在一系列闭合的新鲜胫骨骨折中进行经皮骨髓注射的前瞻性随机试验。

获取原文
获取原文并翻译 | 示例
       

摘要

We performed a prospective, randomized study on 40 patients with fresh closed fractures of the tibial shaft to determine the effect of autologous bone marrow injection on the union rate. Forty patients were randomized to two injections with 15 ml of autologous bone marrow injections at the fracture site and casting or conventional casting. Fracture union measured by absence of localized tenderness and mobility and bridging of three out of four cortices at the fracture site on plain roentgenograms was assessed at 3, 4, and 5 months of treatment. All fractures receiving bone marrow injections united in 3.65+/-0.49 months; 19/20 fractures treated conventionally united in 4.31+/-0.48 months ( p=0.0004). Other possible determinants of union, complication rates, and cost incurred in the treatment were similar in the two groups.
机译:我们对40例新鲜的胫骨干闭合性骨折患者进行了一项前瞻性随机研究,以确定自体骨髓注射对联合发生率的影响。 40名患者被随机分为两组,分别在骨折部位注射15 ml自体骨髓注射液,然后进行铸造或常规铸造。在治疗的第3、4和5个月时,通过无局部压痛和活动性以及在普通X线断层图上的骨折部位桥接四个皮质中的三个皮质来测量骨折愈合。所有接受骨髓注射的骨折均在3.65 +/- 0.49个月内合并;常规治疗的19/20骨折在4.31 +/- 0.48个月内合并在一起(p = 0.0004)。两组其他可能的联合,并发症发生率和治疗费用的决定因素相似。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号